Close Contact Us Now
Tap Here To Call Us

Articles Posted in Publications

Updated:

Legal Intelligencer: Qui Tam Suits and Veil Piercing: A Powerful Combo for Combating Health Care Fraud

This article will discuss briefly the history of qui tam litigation, its interplay with piercing theories and the particular utility of these types of suits in the health care context. In the November 4, 2021 edition of of The Legal Intelligencer, Edward T. Kang of Kang Haggerty co-authored “Qui Tam Suits…

Updated:

Legal Intelligencer: Significant Recent Changes to the Delaware Limited Liability Company Act

This column examines these amendments, the history behind Delaware’s prominence in the realm of corporate law, and discusses some key differences between LLCs and corporations. In the October 14, 2021 editions of The Legal Intelligencer and the Delaware Business Court Insider Edward T. Kang, managing member of Kang Haggerty wrote “Significant…

Updated:

Legal Intelligencer: Enterprise Liability and When to Seek Piercing the Corporate Veil

In this column, we discuss Mortimer, the enterprise theory of liability generally, and the common sequencing decisions plaintiffs need to make when bringing a veil piercing claim. In the September 9, 2021 edition of The Legal Intelligencer, Edward T. Kang of Kang Haggerty co-authored “Enterprise Liability and When to Seek…

Updated:

Legal Intelligencer: ‘Cosby’ and the Use of Prior Bad Acts in the Civil Litigation Context

In the July 22, 2021 edition of The Legal Intelligencer Edward T. Kang of Kang Haggerty co-authored “‘Cosby’ and the Use of Prior Bad Acts in the Civil Litigation Context.” On June 30, the Pennsylvania Supreme Court authored another chapter in the saga of Philadelphia native Bill Cosby. With a…

Updated:

Law Practice Today: Meet NAMWOLF’s New CEO: Leslie Davis

Edward T. Kang, managing member of Kang Haggerty interviewed NAMWOLF’s new CEO Leslie Davis for  The Women in Law Issue of American Bar Association’s Law Practice Today. The National Association of Minority and Women Owned Law Firms (NAMWOLF) recently named attorney Leslie D. Davis as its new chief executive officer, succeeding…

Updated:

Legal Intelligencer: Protective Orders in the Age of E-Discovery

In the July 8, 2021 edition of The Legal Intelligencer Edward T. Kang of Kang Haggerty co-authored “Protective Orders in the Age of E-Discovery.” Electronic discovery and its transformational consequences have been a defining feature of 21st century litigation. The sheer proliferation of data and associated complexity has necessitated the…

Updated:

Legal Intelligencer: A Primer on Pennsylvania’s Participation Theory

In the June 24, 2021 edition of The Legal Intelligencer Edward T. Kang, managing member of Kang Haggerty, wrote “A Primer on Pennsylvania’s Participation Theory.” One of the primary benefits of organizing a business as a corporation (or similar entity) is limited liability protection. By establishing the corporation as a…

Updated:

Legal Intelligencer: Expert Witnesses in Pa.—What Materials Matter in Forming an Opinion?

Over both of counsel’s objections, the judge allowed the witness to continue with his testimony, in accordance with Pennsylvania Rules of Evidence 702 and 703 and the general acceptance test. This scenario raises the question: what materials can an expert witness rely on in Pennsylvania courts, which follows the Frye…

Updated:

Law Practice Today: Zoom Court Appearances: Rising to the Occasion While Seated

In the April 2021 Young Lawyers Issue of Law Practice Today, Kandis Kovalsky wrote “Zoom Court Appearances: Rising to the Occasion While Seated” On March 13, 2020, a national emergency was declared in the United States as a result of the COVID-19 pandemic. Instantly, courts across the country were shuttered.…

Updated:

Legal Intelligencer: Holding Third Parties Liable for Their Role in Perpetuating the Opioid Crisis

The opioid epidemic was a perfect storm, caused by years of over-promotion, over-prescription and dangerous marketing campaigns. Integral to this “perfect storm” was not just the drug manufacturers’ conduct, but also third parties, such as private equity and consulting companies, who all played critical roles. In the April 15, 2021…